Holen Sie sich die Stockscreener-App
72.43
0.03%
-0.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Bio-Techne Gives FTC More Time On $11.3B Merck Deal - Law360
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation? - TradingView
Bio-Techne (Nasdaq: TECH) investors to vote on Merck cash takeover - Stock Titan
Bio-Techne (NASDAQ: TECH) GC gets new RSU grants, no stock sales - Stock Titan
Bio-Techne (NASDAQ: TECH) grants CFO 22,438 and 36,459 RSUs - Stock Titan
Bio-Techne (TECH) director granted 1,381 RSUs vesting 2027-29 - Stock Titan
Bio-Techne (TECH) insider updates stock holdings - Stock Titan
Bio-Techne (NASDAQ: TECH) grants president 8,702 and 14,140 RSUs - Stock Titan
Benchmark reiterates Hold stock rating on Bio-Techne after Q4 results - Investing.com India
BIO-TECHNE Executive Steven C. Crouse Files Form 4 After RSU Vesting and Share Withholding - Kalkine Media
Bio-Techne (TECH) CEO exercises awards, 10.8K shares withheld - Stock Titan
Bio-Techne (TECH) CFO exercises awards, covers taxes in stock - Stock Titan
Bio-Techne (NASDAQ: TECH) exec updates option and RSU holdings - Stock Titan
Bio-Techne (TECH) GC sees RSUs vest, others forfeited on equity awards - Stock Titan
Bio-Techne (TECH) awards give executive 5,423 shares, 1,947 withheld - Stock Titan
Bio-Techne (TECH) director exercises 589 RSUs, uses shares for taxes - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Is Wall Street Bullish or Bearish on Bio-Techne Stock? - Yahoo Finance
Bio-Techne (TECH) Holds Steady at $72.40 as Life Sciences Sector Digests Mixed SignalsOption Strike Build - vinanet.vn
S&CO Inc. Buys Shares of 76,614 Bio-Techne Corp $TECH - MarketBeat
TECH Q2 2026 Earnings: EPS Misses Consensus, Shares Edge HigherMargin Guidance - vinanet.vn
TECH Q2 2026 Earnings: EPS Misses Consensus by 3.34% as Shares Edge HigherSaaS Earnings Trends - vinanet.vn
Bio-Techne Corp (TECH) Stock News Today - tradingkey.com
Wells Fargo Initiates Bio-Techne(TECH.US) With Hold Rating, Announces Target Price $73 - Moomoo
Bio-Techne's Fiscal Q4 Organic Revenue Growth Consistent With Progressive Improvement Story, RBC Says - marketscreener.com
Bio-Techne (NASDAQ:TECH) Downgraded to Equal Weight Rating by Wells Fargo & Company - MarketBeat
Bio-Techne (NASDAQ:TECH) Dividend Move Sparks Fresh Attention - Kalkine Media
TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises - The Globe and Mail
Bio-Techne Keeps Quarterly Dividend at $0.08 a Share, Payable Aug. 28 to Shareholders of Record as of Aug. 24 - marketscreener.com
Bio-Techne Corp (NASDAQ:TECH) to Issue Dividend Increase$0.65 Per Share - MarketBeat
Bio-Techne Dividend Payable Aug. 28 After Record-Date Correction - Stock Titan
Bio-Techne Corp to Issue Quarterly Dividend of $0.08 (NASDAQ:TECH) - MarketBeat
Bio-Techne (NASDAQ:TECH) Releases Earnings Results, Meets Estimates - MarketBeat
Bio-Techne earnings matched, revenue topped estimates - Investing.com
Bio-Techne Announces Q4 and Full Fiscal Year 2026 Financial Results Alongside Cash Dividend Declaration - Kalkine Media
Bio-Techne Q4 Results: Sales rise 1.33% YoY, beat estimates - scanx.trade
Bio-Techne Releases Fourth Quarter Fiscal 2026 Results - investingnews.com
TECH Looks 1.1% Undervalued on GF Value™ Amid High P/E and Mixed Guru Activity - GuruFocus
Techne (TECH) Q4 Earnings Meet Estimates - Yahoo Finance
Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales - Yahoo Finance
Bio-Techne earnings matched, revenue topped estimates By Investing.com - Investing.com South Africa
Bio-Techne beats revenue estimates on research, diagnostics demand uptick - finance.yahoo.com
Bio-Techne declares $0.08 quarterly dividend - Investing.com
Form 8K Bio-Techne Corp For: 12 August By Investing.com - Investing.com Australia
Is Bio-Techne Corp (TECH) Undervalued After Q4 Earnings Beat? GA - GuruFocus
Bio-Techne reports in-line Q4 earnings, beats on revenue - Investing.com
Bio-Techne reports in-line Q4 earnings, beats on revenue By Investing.com - Investing.com India
Bio-Techne Q4 FY2026 earnings: Organic revenue grows 3% as adjusted EPS slips - TradingKey
Bio-Techne Q4 Revenue Rises to $321.2 Million - Quiver Quantitative
Bio-Techne Declares Dividend - Yahoo Finance
Bio-Techne Corp $TECH Stake Decreased by Bank of America Corp DE - MarketBeat
Bio-Techne (TECH) accepts $73-per-share all-cash buyout from Merck KGaA - Stock Titan
Bio-Techne faces quarterly earnings test with Merck deal pending By Investing.com - Investing.com UK
Bio-Techne faces quarterly earnings test with Merck deal pending - Investing.com
Bio-Techne (NASDAQ:TECH) Reaches New 12-Month HighShould You Buy? - MarketBeat
Bio-Techne Corp (TECH) Stock Analysis: Navigating an 11 Billion Dollar Market Cap Amid Modest Growth Challenges - DirectorsTalk Interviews
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):